AMCR vs IP vs SON Stock Comparison

Amcor, International Paper and Sonoco Products Prices as of Nov 2, 2026 Peers: Industry group
1 more company in this comparison (SOLS) Create a free account to keep reading and compare up to 10 companies.
AMCR Amcor plc
$49.03 +17.1% 1M +24.1% 1Y
Market cap
$22.67B
P/E
20.5x
Revenue (TTM)
$23.51B
Div. yield
10.61%
Plastic Packaging Basic Materials
6 wins
SON Sonoco Products Co
$50.20 +3.0% 1M +23.7% 1Y
Market cap
$4.96B
P/E
–
Revenue (TTM)
$7.37B
Div. yield
4.26%
Paper Packaging Basic Materials
2 wins

Head to Head

11 decided of 12

Amcor leads on 6 of the 12 questions below (Amcor 6, International Paper 3, Sonoco Products 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionAMCRIPSONLeader
Larger companyMarket capitalisation $22.67B $23.00B $4.96B IP
Cheaper on earningsLower P/E, profitable companies only 20.5x -5.6x -22.0x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 11.9x 28.0x 9.9x SON
Faster revenue growthRevenue growth, trailing twelve months +56.6% +25.4% +3.6% AMCR
More profitableNet margin, trailing twelve months 4.7% -14.2% -3.1% AMCR
Better return on capitalReturn on invested capital 6.1% 7.5% 2.7% IP
Less leveragedLower net debt / EBITDA 3.8x 1.7x 5.6x IP
Higher dividend yieldTrailing dividend yield 10.61% 5.02% 4.26% AMCR
Better 1-year returnPrice return, last 12 months +24.1% -5.1% +23.7% AMCR
Better 5-year returnAnnualised price return, 5 years -4.4%/yr -6.0%/yr -3.2%/yr SON
Less volatileAnnualised volatility, 1 year 31.7% 42.6% 33.5% AMCR
Higher overall scoreMean of the five percentile scores vs peers 67/100 62/100 37/100 AMCR

Percentile Scorecard

AMCRIPSON

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisAMCRIPSON
Valuation 31 #12 of 17 56 #8 of 17 44 #10 of 17
Growth 100 #1 of 16 47 #9 of 16 20 #13 of 16
Profitability 73 #5 of 16 47 #9 of 16 40 #10 of 16
Financial Health 38 #11 of 17 81 #4 of 17 25 #13 of 17
Shareholder Returns 92 #2 of 14 77 #4 of 14 54 #7 of 14
Overall 67 62 37
  • AMCR ranked among 17 companies in Packaging
  • IP ranked among 17 companies in Packaging
  • SON ranked among 17 companies in Packaging

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodAMCRIPSONSPY
1 month +17.1%+14.7%+3.0% -2.3%
3 months +6.5%-11.5%-11.0% -0.7%
6 months +32.8%+17.6%+1.2% +4.8%
Year to date +17.6%-6.9%+15.0% +10.3%
1 year +24.1%-5.1%+23.7% +10.3%
3 years +7.6%+6.0%-8.9% +73.0%
3 years, per year +2.5%+2.0%-3.1% +20.1%
5 years -20.3%-26.5%-14.8% +61.9%
5 years, per year -4.4%-6.0%-3.2% +10.1%
10 years —-17.0%+0.7% +258.6%
10 years, per year —-1.8%+0.1% +13.6%

Risk

MeasureAMCRIPSONSPY
Volatility, 1Y 31.7%42.6%33.5% 12.8%
Downside volatility, 1Y 28.5%39.6%36.6% 12.8%
Beta vs S&P 500, 1Y 0.781.130.38 1.00
Return / volatility, 1Y 0.76-0.120.71 0.80
Max drawdown, 5Y -45.6%-51.1%-41.2% -25.4%
From 52-week high -3.1%-25.4%-17.1% -3.5%
52-week high $50.58$49.19$60.55 $779.14
52-week low $36.69$29.38$39.77 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleAMCRIPSON
P/E now vs peer median 20.5xmedian 20.5x -5.6xmedian 20.5x -22.0xmedian 20.5x
P/S now vs peer median 1.0xmedian 0.7x 1.0xmedian 0.7x 0.7xmedian 0.7x
EV/EBITDA now vs peer median 10.4xmedian 10.0x 6.4xmedian 10.0x 12.4xmedian 10.0x
P/FCF now vs peer median 18.4xmedian 16.5x 46.7xmedian 16.5x 14.1xmedian 16.5x
P/B now vs peer median 1.9xmedian 1.5x 1.6xmedian 1.5x 1.8xmedian 1.5x
PEG now vs peer median -1.65median 0.83 0.09median 0.83 0.63median 0.83

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsAMCRIPSON
Revenue $23.51B $24.20B $7.37B
Gross profit $4.69B $7.21B $1.49B
Operating income $1.90B $2.13B $202.22M
Net income $1.11B -$3.44B -$226.84M
Free cash flow $1.23B $492.00M $351.16M
R&D $170.00M – –
EPS (diluted) $2.38 $-6.49 $-2.29
Cash & equivalents $1.12B $726.00M $183.10M
Total debt $14.01B $9.22B $4.29B
Shares (diluted) 463.80M 529.50M 99.50M
Enterprise value $18.10B $18.90B $4.03B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricAMCRIPSON
P/E 20.5x -5.6x -22.0x
P/FCF 18.4x 46.7x 14.1x
P/Operating cash flow 10.5x 8.7x 7.9x
P/S 1.0x 1.0x 0.7x
P/B 1.9x 1.6x 1.8x
P/Tangible book 4.3x 2.2x 14.9x
EV/EBITDA 10.4x 6.4x 12.4x
EV/EBIT 18.7x 14.8x 44.9x
EV/Revenue 1.5x 1.3x 1.2x
EV/FCF 28.9x 64.0x 25.8x
EV/Operating cash flow 16.5x 11.9x 14.4x
PEG (3Y EPS CAGR) -1.65 0.09 0.63

Growth

14 metrics
MetricAMCRIPSON
Revenue growth (1Y) 56.6% 25.4% 3.6%
Revenue CAGR (3Y) 17.0% 6.1% 18.9%
Gross profit growth (1Y) 65.5% 32.6% -1.3%
Gross profit CAGR (3Y) 19.8% 7.9% 13.7%
Operating income growth (1Y) 88.2% 6.8% -63.5%
Operating income CAGR (3Y) 8.0% -13.8% -30.2%
Net income growth (1Y) 113.5% -12,633% -136.1%
Net income CAGR (3Y) 1.5% -74.4% -35.0%
EPS growth (1Y) 48.7% -12,708% -136.3%
EPS CAGR (3Y) -12.4% -60.9% -35.0%
Operating cash flow growth (1Y) 54.7% 139.3% -6.3%
Operating cash flow CAGR (3Y) 19.5% 8.6% -7.8%
Free cash flow growth (1Y) 51.7% 516.9% 17.9%
Free cash flow CAGR (3Y) 18.7% -18.3% -8.4%

Profitability

14 metrics
MetricAMCRIPSON
Gross margin 20.0% 29.8% 20.2%
EBITDA margin 14.6% 20.4% 9.9%
Operating margin 8.1% 8.8% 2.7%
Pretax margin 5.5% -13.5% -0.1%
Net margin 4.7% -14.2% -3.1%
FCF margin 5.2% 2.0% 4.8%
Operating cash flow margin 9.2% 10.9% 8.6%
Return on equity 9.4% -23.5% -7.1%
Return on assets 3.0% -9.4% -2.1%
Return on invested capital 6.1% 7.5% 2.7%
Return on capital employed 6.4% 7.3% 2.5%
Asset turnover 0.6x 0.7x 0.7x
Cash conversion (OCF / net income) 1.9x -0.8x -2.8x
Stock comp / revenue 0.4% – 0.2%

Financial Health

11 metrics
MetricAMCRIPSON
Debt / assets 37.8% 25.2% 42.3%
Debt / equity 1.2x 0.6x 1.5x
Net debt / EBITDA 3.8x 1.7x 5.6x
Debt / FCF 11.4x 18.7x 12.2x
Liabilities / assets 68.2% 60.4% 72.2%
Equity / assets 31.8% 39.6% 27.8%
Interest coverage 2.8x 6.2x 1.1x
Current ratio 1.3x 1.1x 1.2x
Quick ratio 0.6x 0.7x 0.6x
Cash ratio 0.1x 0.1x 0.1x
Altman Z-score 1.42 1.67 1.62

Shareholder Returns

7 metrics
MetricAMCRIPSON
Dividend yield 10.6% 5.0% 4.3%
Net buyback yield 0.0% 0.1% 0.2%
Shareholder yield 10.6% 5.2% 4.4%
Payout ratio (earnings) 108.0% – -93.2%
Payout ratio (FCF) 97.2% – 60.2%
Dividend growth (1Y) 41.4% – 2.3%
Dividend CAGR (3Y) 18.2% – 2.7%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusAMCRIPSON
Forward P/E 11.9xFY2027 28.0xFY2026 9.9xFY2026
EPS, next fiscal year $4.12FY2027 $1.31FY2026 $5.09FY2026
EPS growth, next FY +2.5%FY2027 – -10.9%FY2026
EPS growth, the year after +9.2% +122.1% +17.5%
Revenue, next fiscal year $23.41BFY2027 $23.04BFY2026 $7.65BFY2026
Revenue growth, next FY -0.4%FY2027 -2.5%FY2026 +1.7%FY2026
Revenue growth, the year after -2.2% +17.4% -5.9%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersAMCRIPSON
Held by institutions 77.1% 85.3% 97.9%
Institutions holding 686 857 509
Change in shares held, QoQ +3.7% +4.9% +13.2%
Institutions buying 411 454 266
Institutions selling 211 283 160
Buyers to sellers 1.95 1.60 1.66

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

AMCRIPSON
AMCR 1.00 0.62 0.57
IP 0.62 1.00 0.51
SON 0.57 0.51 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, AMCR, IP and SON?

International Paper (IP) is the largest by market capitalisation: Amcor (AMCR) $22.67B, International Paper (IP) $23.00B, Sonoco Products (SON) $4.96B.

Which company is growing faster?

Amcor (AMCR) grew revenue fastest over the trailing twelve months: Amcor (AMCR) +56.6%, International Paper (IP) +25.4%, Sonoco Products (SON) +3.6%.

Which company is more profitable?

Amcor (AMCR) has the highest net margin (Amcor (AMCR) 4.7%, International Paper (IP) -14.2%, Sonoco Products (SON) -3.1%). On return on invested capital, International Paper (IP) leads (Amcor (AMCR) 6.1%, International Paper (IP) 7.5%, Sonoco Products (SON) 2.7%).

Which stock has performed better?

Over the past year Amcor (AMCR) returned the most: Amcor (AMCR) +24.1%, International Paper (IP) -5.1%, Sonoco Products (SON) +23.7%. Over five years, Sonoco Products (SON) compounded fastest (Amcor (AMCR) -4.4%/yr, International Paper (IP) -6.0%/yr, Sonoco Products (SON) -3.2%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Amcor (AMCR) has the highest dividend yield: Amcor (AMCR) 10.61%, International Paper (IP) 5.02%, Sonoco Products (SON) 4.26%.

Which stock is riskier?

By one-year price volatility, Amcor (AMCR) has been the steadiest (Amcor (AMCR) 31.7%, International Paper (IP) 42.6%, Sonoco Products (SON) 33.5%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, AMCR, IP and SON?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Amcor (AMCR) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.